SKF 107647
Alternative Names: HP 5Latest Information Update: 01 Oct 1998
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 01 Oct 1998 Discontinued-II for Bacterial infections in USA (Unknown route)
- 25 May 1995 New profile
- 25 May 1995 Phase-II clinical trials for Bacterial infections in USA (Unknown route)